Cardiac patients
A recent study published in Biomarkers in Medicine has identified the triglyceride-glucose (TyG) index as a novel biomarker for mild cognitive impairment in patients with coronary artery disease (CAD). The study, conducted by a team of researchers from Capital Medical University, included 1163 patients with CAD who underwent cognitive function
Type 2 diabetes
Research published in the Skin Appendage Disorders journal has highlighted the dermatologic effects associated with the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of medications primarily used to manage type 2 diabetes and obesity. According to the study, GLP-1RAs can cause various dermatologic effects, including injection-site reactions, immune-mediated
Type 2 diabetes
A recent study published in the BMC Cardiovascular Disorders journal has uncovered a significant association between the triglyceride-glucose (TyG) index and arteriosclerosis in patients with type 2 diabetes. The research, conducted at the Third Affiliated Hospital of Soochow University, involved 410 patients with type 2 diabetes mellitus (T2DM) and revealed
Type 2 diabetes
Data from a recent study conducted by researchers from the First Affiliated Hospital of Guangxi Medical University and Key Laboratory of Clinical Laboratory Medicine of Guangxi have revealed a staggering 37.52% prevalence of abnormal glucose metabolism among the Zhuang population in Nanning, China. The study, which involved a comprehensive
Type 2 diabetes
A new study published in Science Advances has shed light on the role of TRAF6 in regulating glucose homeostasis through Parkin-dependent and Parkin-independent mitophagy. Researchers at the University of Michigan found that TRAF6 integrates innate immune signals following diet-induced obesity to promote glucose homeostasis. This is contrary to the prevailing
Sensors
A new wearable wristband has the potential to significantly improve diabetes management by continuously tracking glucose, lactate, and alcohol levels, as well as cardiovascular signals. This innovative device, developed by researchers at the University of California San Diego, uses a microneedle array to painlessly sample interstitial fluid and measure glucose,
Sensors
Researchers at the Department of Sciences have made significant advancements in the development of cobalt-telluride (CoTe2) nanomaterials, which have shown outstanding performance in energy storage and glucose sensing applications. The team, led by Ibrahim K. Alsulami, has utilized a simple and inexpensive hydrothermal method to craft CoTe2 electrodes with impressive
Sensors
Researchers from Old Dominion University have made a significant contribution to the field of diabetes management by developing a non-enzymatic electrochemical glucose sensor based on laser-induced graphene (LIG), functionalized with zinc oxide (ZnO) and palladium (Pd) nanostructures. The sensor exhibits a wide dynamic range, capturing hypo- and hyperglycemia conditions, and
Sensors
Researchers from the University of Mumbai have successfully developed a non-enzymatic electrochemical glucose sensor using nanoparticles. The sensor has shown high sensitivity and selectivity towards glucose, detecting concentrations as low as 0.0009 mM and quantifying up to 6.0 mM. This breakthrough has significant implications for the diagnosis and
Sensors
Researchers at the Huazhong University of Science and Technology have developed a wearable noninvasive glucose sensor using nanotechnology, enabling continuous monitoring of glucose levels in sweat with high sensitivity and minimal risk. The system integrates a flexible microfluidic glucose sensor patch with a flexible printed circuit board for signal analysis
